Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

09. Januar 2026 02:30 ET | Quelle: Allegro NV

Allegro to start production of osteoarthritis hydrogel as it prepares for clinical trials

Wallonia Minister of Economy and Employment Pierre-Yves Jeholet will perform opening ceremony on 9 January 2026New cleanroom facility allows production of one million doses per yearRamping up for...
03. September 2025 02:30 ET | Quelle: Allegro NV

Allegro appoints life sciences veteran as Chief Operating Officer to advance osteoarthritis treatment

Stephan Crokaert, formerly of NeoMedLight, Abbott, Adagio and Boston Scientific, brings more than 35 years of strategic and commercial experience in life sciencesAllegro prepares to advance lead...
04. März 2025 02:30 ET | Quelle: Allegro NV

Allegro reports positive safety data for its injectable osteoarthritis treatment in three preclinical studies

Hydrocelin is potentially a first-in-class disease-modifying injectable treatment for osteoarthritisPivotal clinical trial in osteoarthritis patients on track to start in 2025 Liege, Belgium – 4...
11. Dezember 2024 01:30 ET | Quelle: Allegro NV

Allegro’s osteoarthritis injectable shock absorbing gel demonstrates preclinical safety

Clean systemic toxicity profile and no local side-effects following injection Tiny shock absorbing microparticles support and enhance synovial fluidDesigned as potential first-in-class...